Citigroup Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $23
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
Citigroup analyst Joanne Wuensch initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $23.
Citigroup analyst Joanne Wuensch initiates coverage on Minimed Group (NASDAQ:MMED) with a Buy rating and announces Price Target of $23.